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IL-12Rβ1nses and dendritic cell (DC) functions are compromised in HIV-1 infected
individuals. To better understand these immune abnormalities, we developed an HIV-1 transgenic (Tg) rat.
We report that Tg DCs induce elevated levels of SOCS-1 and secrete decreased IL-12p40 and elevated levels of
IL-10 following TLR-4 stimulation by LPS. This leads to further induction of SOCS-1 by IL-10 and decreased
IFN-γ-mediated induction of interferon response factor (IRF)-1 and IL-12Rβ1 expression in CD4+ T cells and
to decreased IL-12-induction of IFN-γ production by Th1 polarized T cells. We also show that SOCS-1 is
elevated in CD4+ T cells from HIV-1 infected progressors, and is correlated with defective induction of IRF-1
following IFN-γ stimulation, compared with healthy controls and HIV-1 natural viral suppressor (NVS)
patients. These results suggest a link between high levels of SOCS-1, defects in innate immunity and adaptive
Th1 responses that may be reﬂected in the loss of Th1 immune competence observed with AIDS patients.
© 2008 Elsevier Inc. All rights reserved.IntroductionHIV-1 infection elicits host immune responses that include
dysregulation of regulatory pathways for cytokine expression that
are characterized by decreased production of pro-inﬂammatory
cytokines including IL-12 and IFN-γ and increased expression of the
anti-inﬂammatory cytokine IL-10, the latter of which has been
identiﬁed as a factor responsible for impaired innate and T helper
type 1 (Th1) responses in AIDS patients (Ma and Montaner, 2000).
Although the IFN-γ-IL-12 signaling network is likely pivotal to the Th1
differentiation program and immune control of HIV-1 infection (Kano
et al., 2008; Murphy et al., 2000), the underlying mechanisms are
largely uncharacterized.
Innate immunity provides the initial host protective response to
infectious danger. Recognition of a wide variety of microbes depends
upon toll like receptors (TLRs), which recognize conserved microbial
structures. Stimulation of TLRs on DC results in secretion of pro-
inﬂammatory cytokines and increases effector functions such asof the University of Maryland
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.
of Medicine, PA 19104, USA.
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l rights reserved.phagocytosis and the ability to present antigen to T cells. Although
innate immunity represents a powerful system to combat exogenous
invaders, many infections can only be cleared in combination with
adaptive immunity. In this respect, IFN-γ and IL-12 play a critical role
by enhancing activation of macrophages and DC and increasing
antigen presentation and Th1 memory development/maintenance
(Boehm et al., 1997;Trinchieri, 2003).
During initiation of the adaptive immune response, co-stimulation
of DCs with LPS or other agents induces production of IL-12, a 70 kDa
heterodimeric cytokine composed of 35 kDa (p35) and 40 kDa (p40)
subunits. IL-12 binds to a cell surface receptor composed of β1 (IL-
12Rβ1) and β2 (IL-12Rβ2) subunits (Trinchieri, 2003), leading to
activation of natural killer (NK), NKT, and memory T cells to produce
cytokines (particularly IFN-γ) that favor differentiation of cells that
produce type-1 (Th-1) cytokines and Th1-associated classes of
immunoglobins. The engagement of the IL-12R on T cells triggers
activation of the Janus kinases Tyk2 and JAK2, which are associated
with the IL-12Rβ1 and IL-12Rβ2 cytoplasmic domains, respectively.
This results in activation of the transcription factor signal transducer
and activator of transcription-4 (STAT4), which is critical for the
generation of Th1 responses (Trinchieri, 2003). Through positive
paracrine feedback, IFN-γ enhances IL-12 production from DCs and
leads to increased T cell responsiveness to IL-12 by inducing the
expression of IRF-1 which is essential for regulating the expression of
IL12Rβ1 (Szabo et al., 1997;Trinchieri, 2003; Kano et al., 2008;Murphy
et al., 1994). In the absence of IRF-1, naïve CD4+ T cells do not
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the molecular level, IFN-γ interacts with its receptor, resulting in
activation of Jak1 and Jak2 as well as phosphorylation of STAT1 which
results in the induction of IFN-responsive gene transcription (Dalpke
et al., 2003).
The IFN-γ-IL-12 signaling pathways are central in controlling both
environmental and endogenous challenges (Rosenzweig and Holland,
2005). Prolonged incubation of DC with LPS and/or IFN-γ eventually
results in decreased IL-12 production consequent to induction of
expression of a family of eight suppressor of cytokine signaling (SOCS)
proteins, each of which play a unique role in inhibiting cellular
signaling. SOCS1 provides a major negative feedback for attenuating
immunostimulatory functions; it negatively regulates IFN-γ, IL-2, IL-6,
IL-4, TNF-alpha and IL-15 signaling through inhibition of JAKs in many
lineages of immune cells (Alexander and Hilton, 2004; Kubo et al.,
2003). SOCS1 binds to the JAK activation loop through its Src-
homology 2 (SH2) domain and targets JAK2 for degradation, leading to
inhibition of STAT activation (Kubo et al., 2003;Alexander and Hilton,
2004). SOCS-1 can also inhibit non-JAK–STAT signaling, such as that
elicited by TNF and LPS (Chong et al., 2002; Kinjyo et al., 2002). The
precise mechanisms by which SOCS-1 dampens LPS signaling and
immune responses in DCs is not entirely clear, but may involve
regulation of antigen presentation, co-stimulation and cytokine
production by mature DCs via a mechanism mediated by Mal
(MyD88 adapter-like protein) (Mansell et al., 2006).
It is not clear whether AIDS-related functional impairment of DCs
is a result of their direct infection by HIV-1 or is indirect. Indirect
mechanisms could involve exposure to virally encoded or induced
proteins or chronic antigenic stimulation. Reports conﬂict on the
extent to which DCs are infected with HIV; however, a recent report
shows that a subset of myeloid DCs is infected (Granelli-Piperno et al.,
2006). These infected DCs do not mature in response to a panel of
stimuli, produce reduced levels of IL-12p40, increased levels of IL-10
(an inhibitor of IL-12 production) and exhibit very weak immunos-
timulatory functions after stimulation. However, because the extent of
DC infection is generally thought to be rather limited in vivo, it is
thought that indirect mechanisms play a central role in DC dysfunc-
tion in HIV disease (Ma and Montaner, 2000). During HIV infection,
cytokines are hyper-expressed; many are inducers of and regulated by
SOCS-1 (Alexander and Hilton, 2004; Kubo et al., 2003).
Understanding the mechanisms by which long-lived immune
responses are maintained is of intrinsic interest, but will also be
important in the development of an effective HIV-1 vaccine. We haveFig. 1. Extracellular IL-12p40 and IL-10 expression by DC. To analyze extracellular IL-12p40 an
capture ELISA. BMDCwere stimulatedwith LPS andmediawas collected and analyzed in duplic
and 48 h. stimulation comparedwith 4789±2231 pg/ml and 5825±3320 by age-matched contro
pg/ml after 24 compared with 13±11 for age matched controls. ⁎Indicates a signiﬁcant differeearlier reported that HIV-1 Tg rats have defects in the generation/
maintenance of effector/memory phenotype T cell subsets, type 1
cytokine production and type 1 cytokine responses (Reid et al., 2001,
2004; Yadav et al., 2006). Here we show that IL-10 induced over-
expression of SOCS-1 by CD4+ T cells and DC is likely responsible for
the quantitative and qualitative deﬁciencies in effector memory Th1
responses in Tg rats by disruption of the IL-12-IFN-γ signaling axis. We
also report that IL-12p40 production following IFN-γ/LPS stimulation
of BMDCs from HIV-1 Tg rats is increased by knocking down SOCS-1
expression. We show that SOCS-1 mRNA is elevated in CD4+ T cells
from HIV-1 infected progressor patients and that this is correlated
with decreased IRF-1 induction following IFN-γ stimulation relative to
healthy controls and HIV-1 Natural Viral Suppressors (HIV infected
patients who have undetectable HIV-1 viral loads without therapy).
The results suggest a previously undescribed link between high levels
of SOCS-1, defects in the innate immune response as determined by
LPS induction of IL-12p40 in BMDCs, and dysregulation in adaptive
Th1 effector memory responses.
Results
HIV-1 Tg rat BMDCs express reduced IL-12 and increased IL-10 following
LPS activation
The dysregulated IFN-γ production, reduced delayed type
hypersensitivity and low numbers of T cells with a Th1 effector/
memory phenotype seen with HIV-1 Tg rats suggested that the
microenvironment in which antigen speciﬁc T cells receive activation
signals was unfavorable to Th1 responses, development and/or
maintenance. Since cytokine expression by DCs is critical for these
processes, we tested expression by DCs of cytokines that regulate Th1
responses. Capture ELISAs for IL-12p40 and IL-10 of culture super-
natants from LPS (1 μg/ml)-activated puriﬁed BMDC from mature Tg
and control rats showed (Fig. 1A) that IL-12p40 expression by Tg rat
BMDC was fourfold lower [1089±807 pg/ml and 1226±883 after 24 h
(p=0.002) and 48 h (p=0.002) respectively]than that of age-matched
controls (4789±2231 pg/ml and 5825±3320). IL-10 expression from
Tg BMDC was 73±61 pg/ml (p=0.015) 24 h post-stimulation
compared with 13±11 pg/ml for age matched controls (Fig. 1B). IL-
12/IL-10 ratios at 24 h post-stimulation are thus remarkably skewed
(∼14 for the Tg BMDC compared with ∼360 for controls), suggesting
that Th1/Th2 cytokine expression is highly dysregulated in a way that
would lead to a lack of proper BMDC function.d IL-10 production, culture supernatants from Tg and control rats (n=6) were assayed by
ate. (Panel A), expression of IL-12 by Tg BMDCwas 1089±807 pg/ml and 1226±883 at 24 h
ls at the same time points. (Panel B), IL-10 expression by Tg BMDCwas 73±61 pg/ml (n=6)
nce by Mann–Whitney test for samples exhibiting non-normal distribution.
Fig. 2. Relative increase in SOCS-1 mRNA in BMDCs. BMDC from Tg and control rats (n=4) were stimulated with 1 μg/ml of LPS for 24–48 h or IFN-γ at 10 ng/ml for 1–3 h. (A, B)
shows expression of SOCS-1 mRNA by BMDC. Levels of SOCS-1 mRNAwere determined by real-time quantitative RT-PCR as described in the text. Samples were analyzed in triplicate
and data normalized to the expression of 18S ribosomal RNA. SOCS-1 mRNA from BMDC of Tg was increased approximately 26 and 9.0-fold following 3 h IFN-γ and 48 h LPS
stimulation, respectively compared with 15 and 2-fold increase in the non-Tg control. ⁎Indicates a signiﬁcant difference by Mann–Whitney test for samples exhibiting non-normal
distribution.
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stimulation
As IL-12 production is positively regulated by IFN-γ and LPS
stimulation and negatively regulated by SOCS-1 (Trinchieri, 2003), we
hypothesized that low expression of IL-12p40 by DC would be
correlated with increased expression of SOCS-1 following stimulation
with IFN-γ and/or LPS. Figs. 2A, B show that Tg BMDC cells had a 1.8
(Pb0.05) and 4.5 fold, (Pb0.04) increase in SOCS-1 mRNA relative to
unstimulated controls following IFN-γ and LPS stimulation, respec-
tively. Baseline SOCS-1 mRNA levels in unstimulated Tg BMDC relative
to controls were also 1.5 fold higher (data not shown). These data
suggest that SOCS-1 expression is dysregulated in Tg BMDCs and may
down-regulate IL-12p40 expression.Fig. 3. Increase in IL-12p40 production in BMDCs following SOCS-1 siRNA nucleofection. BMD
48 h following SOCS-1 siRNA nucleofection. Fig. 3 shows expression of IL-12p40 productio
IL-12p40 production from SOCS-1 siRNA treated Tg BMDC increased approximately 2-fold fol
compared with siRNA-untargeted samples (1494 pg/ml and 143 pg/ml). siRNA-treated cont
untreated samples (2974 pg/ml and 367 pg/ml). This ﬁgure is representative of two separatReduced SOCS-1 mRNA expression increases IL-12p40 production
following LPS and IFN-γ stimulation of immature HIV-1 Tg rat BMDCs
As SOCS-1 negatively regulates IL-12 production following LPS
stimulation and because of the positive effect of IFN-γ signaling on IL-
12 production, we postulated whether siRNA knockdown of SOCS-1
expression in DC would elevate IL-12p40 expression. We nucleofected
BMDCs with ON-TARGET Plus non-targeting siRNA Pool as a negative
control and Cyclophilin B SMART Pool siRNA as a positive control for
nucleofection/knockdown efﬁciency and obtained a calculated N90%
transduction efﬁciency using the Dharmacon algorithm. Figs. 3A, B
shows that the ON-TARGET plus SOCS-1 siRNA SMART pool knocked
down SOCS-1 mRNA expression in control and Tg DC by averages
of 52% and 47%, respectively, at 48 h after stimulation with LPS andC from Tg and control rats were stimulated with 1 μg/ml of LPS or IFN-γ at 10 ng/ml for
n by BMDC following siRNA treatment, determined by ELISA as described in the text.
lowing 48 h of LPS (A) or IFN-γ (B) stimulation (2424 pg/ml and 322 pg/ml), respectively,
rols were 1.5-fold increased (4563 pg/ml and 553 pg/ml), respectively, compared with
e experimental studies.
Fig. 4. Relative increase in SOCS-1 and IRF-1 mRNA in CD4+ T cells. CD4+ T cells from Tg and control rats were stimulated with 10 ng/ml IFN-γ for 1–3 h. Panel A shows expression of
SOCS-1 mRNA by CD4+ T cells. Levels of SOCS-1 mRNA were determined by real-time quantitative RT-PCR as described in the text. Samples were analyzed in triplicate and data
normalized to the expression of 18S ribosomal RNA. Baseline SOCS-1 mRNA from Tg CD4+ T cells was approximately 2-fold elevated compared to non-Tg control and increased 4.7-
fold following 1 h of IFN-γ treatment, compared with 1.1-fold increase in controls. Panel B shows that induction of IRF-1 in Tg CD4+ T cells was 1.9 and 2.4-fold at 1 and 3 h
respectively, versus induction in control CD4+ T cells of 5.0 and 6-fold. Baseline expression of IRF-1 in unstimulated Tg CD4+ T cells was 1.8-fold higher than controls. ⁎Indicates a
signiﬁcant difference by Mann–Whitney test for samples exhibiting non-normal distribution. ⁎⁎Indicates a signiﬁcant difference by comparing the lower 95% conﬁdence limit of the
Tg sample (lower limit value of 1.5) to the non-Tg control (lower limit value of 1.0).
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control cells, inversely proportional to the 50% knockdown of SOCS1
mRNA. Although the data show single representative control and Tg
animals, Figs. 3A, B is representative of two experimental studies and
have given generally similar results, suggesting that elevated SOCS-1
mRNA expression in Tg BMDC causes reduced IL-12p40 secretion in
response to LPS and IFN-γ stimulation, and that this can be normal-
ized by inhibiting SOCS-1 expression. Although IL-12p40 by Tg BMDC
does not reach the level of control cells, due to their intrinsic higher
levels of SOCS-1 mRNA compared to controls, more efﬁcient SOCS1
knockdown would likely further increase IL-12p40 secretion.
HIV Tg rat CD4+ T cells express elevated levels of SOCS-1 and lower levels
of IRF-1after IFN-γ stimulation
As IFN-γ responses are mediated through STAT-1 activation and
because induction of SOCS-1 and IL-12Rβ1 by IFN-γ requires interferon
regulatory factor-1 (IRF-1), a downstream target of STAT1, we asked
whether high SOCS-1mRNA expression in Tg CD4+ Tcells is correlated
with elevated basal expression of IRF-1. CD4+ T cells (n=5) were
stimulatedwith 10 ng/ml of IFN-γ for 0,1 h and 3 h and analyzed byRT-
PCR. Fig. 4A shows that 1 h after IFN-γ stimulation, Tg CD4+Tcells had aFig. 5. Impaired IL-12Rβ1 mRNA and secondary IFN-γ expression from Th1 polarized T ce
stimulated for 3 and 5 days under Th1 conditions. Samples were analyzed in triplicate and d
cells (n=4) was increased 1.5 and 1.8-fold following 3 and 5 days under Th1 conditions, com
shows IFN-γ expression when day 5 Th1 T cells were rested overnight and then pulsed with
IFN-γ by ELISA. Interferon-gamma production from Tg (n=5) Th1 conditioned cells was 3
signiﬁcant difference by Mann–Whitney test for samples exhibiting non-normal distributio4.0 fold increase (p=0.028) in SOCS-1 mRNA relative to non-Tg controls.
Importantly, basal expression of SOCS-1 in unstimulated Tg CD4+ T cells
was signiﬁcantly elevated more than 2 fold higher than that of the
controls. Fig. 4B shows that IRF-1 mRNA expression in CD4+ T cells was
induced 6.4 fold (p=0.028) in control cells relative to Tg cells 3 h after
IFN-γ stimulation. However, expression of IRF-1 mRNA in unstimulated
Tg cells was 1.8-fold higher than in the controls. These data suggest that
themore rapid inductionkineticsof SOCS-1mRNA inTg cells is a result of
high baseline levels of IRF-1; failure to further elevate IRF-1 expression
following treatment with IFN-γ is indicative of a defect in IFN-γ
mediated signal transduction pathways, likely due to the elevated
SOCS-1 expression in Tg CD4+ T cells.
HIV-1 Tg rat Th1 polarized cells express reduced levels of IL-12Rβ1 mRNA
and IFN-γ protein after stimulation
Consistent with the results in Fig. 4B showing a failure to induce
IRF-1 mRNA in Tg CD4+ T cells, Fig. 5A shows that induction of the
IRF-1 responsive gene IL-12Rβ1 was abrogated in Tg CD4+ T cells
cultured for 5 (p=0.03) days under Th1 polarizing conditions. Fig. 5B
demonstrates that when day 5 Th1 polarized Tg cells were washed,
rested overnight and re-stimulated with rat IL-12 (1 ng/ml), theylls. Panel A shows IL-12Rβ1 mRNA expression when puriﬁed naïve CD4 T cells were
ata normalized to the expression of 18S ribosomal RNA. IL-12Rβ1 mRNA from Tg CD4+ T
pared with 4.1 and 7.2 -fold increase in the non-Tg control (n=4) respectively. Panel B
1 ng/ml rIL-12 for 24 h as described in the text. Samples were analyzed in duplicate for
2±38 pg/ml compared with 528±660 pg/ml from non-Tg control (n=4). ⁎Indicates a
n.
Fig. 6. IL-10 induction of SOCS-1 mRNA in non-Tg control CD4+ T cells. Panel A shows CD4+ T cells from non-Tg controls stimulated with rIL-10 (10 ng/ml) for 1 h. Shown is the
expression of SOCS-1 mRNA in control CD4+ T cells. Levels of SOCS-1 mRNAwere determined by real-time quantitative RT-PCR as described in Materials and methods. Samples were
analyzed in triplicate and data normalized to the expression of 18S ribosomal RNA. SOCS-1 mRNA from CD4+ T cells (n=4) was increased 1.5 fold relative to un-stimulated controls.
Panel B shows CD4+ T cells from non-Tg controls were cultured for 18 h in supernatants from LPS stimulated Tg and non-Tg control BMDC samples with/without added anti-IL-10
(50 ng/ml) antibody. Shown is the expression of SOCS-1 mRNA in control CD4+ T cells. Levels of SOCS-1 mRNAwere determined by real-time quantitative RT-PCR as described above.
Samples were analyzed in triplicate and data normalized to the expression of 18S ribosomal RNA. SOCS-1 mRNA from CD4+ T cells (n=4) cultured in stimulated BMDC non-Tg control
supernatant was increased 2.2 fold and decreased to 1.2 fold when anti-IL-10 antibody was added relative un-stimulated controls. SOCS-1 mRNA from CD4+ T cells (n=4) cultured in
stimulated BMDC Tg supernatant was increased 4.4-fold and decreased to 2.4 fold when anti-IL-10 antibody was added. Interestingly, basal SOCS-1 mRNA expression for cells
cultured in Tg un-stimulated supernatants was 2.7-fold higher than un-stimulated non-Tg controls. ⁎Indicates a signiﬁcant difference by Paired T-test. ⁎⁎Indicates a signiﬁcant
difference by comparing the lower 95% conﬁdence limit of CD4 T cells cultured in un-stimulated Tg BMDC Supernatant (lower limit value of 1.4) to un-stimulated Non-Tg BMDC
Supernatant (lower limit value of 1.0).
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results suggest that SOCS-1 induction by high baseline levels of IRF-1
is defective for IL-12Rβ1-mediated IFN-γ production, IL-12-INF-γ
signaling and maintenance of effector/memory Th1 lineage cells in
HIV-1 Tg rats. It is tempting to speculate that a similar mechanism
disrupts Th1 responses in HIV-1 infected patients.
IL-10 induction of SOCS-1 expression in non-Tg CD4+ T cells
Because Tg BMDC secreted elevated levels of IL-10 following LPS
stimulation (Fig. 1B), and because IL-10 induces SOCS-1 expression in
dendritic and CD4+ T cells (Ding et al., 2003), we ﬁrst measured SOCS-
1 mRNA levels in control rat CD4+ T cells following 1 h of treatment
with 10 ng/ml of rIL-10. SOCS-1 mRNA increased 1.5 fold (p=0.047)
relative to unstimulated controls Fig. 6A. Fig. 6B shows that control rat
CD4+ T cells cultured for 18 h in supernatants from BMDC stimulatedFig. 7. Dysregulation of SOCS-1 and IRF-1 mRNA in CD4 T cells from HIV-1 infected patient s
patients (progressor) and HIV-1 infected NVS patents were stimulated with 10 ng/ml IFN-γ
mRNAwere determined by real-time quantitative RT-PCR as described in the text. Samples w
SOCS-1 mRNA induction at 1 and 3 h following IFN-γ stimulation for healthy controls [1.7 a
progressive disease patients SOCS-1 levels were 3.2 and 2.2-fold increased. Panel B shows th
2.2-fold at 1 and 3 h respectively, versus induction in NVS CD4 Tcells of 3.9 and 2.7 and contro
and Dunn's multiple comparisons test.with LPS for 24 h (as shown in Fig. 1B) elevated SOCS-1 mRNA 2.2 and
a 4.4 fold in control and Tg samples, respectively, relative to
unstimulated controls. Consistent with the idea that IL-10 induces
SOCS-1 expression in CD4+ T cells, treatment of these supernatants
with anti-IL-10 antibody reduced SOCS-1 mRNA induction to 1.2 and
2.4-fold in control and Tg samples, respectively. Interestingly, basal
expression of SOCS-1 mRNA was elevated 2.7-fold when CD4+ T cells
were cultured in supernatants from unstimulated Tg BMDC relative to
unstimulated control BMDC. These data suggest that the increased
levels of SOCS-1 observed with Tg rats are indeed due to elevated
expression of IL-10. The inability of anti-IL-10 to completely reduce
SOCS-1 induction in CD4+ T cells by supernatants may be because
other anti-inﬂammatory cytokines also play a role in SOCS-1 induction
in Tg rats. Alternatively, it may be that we incompletely inhibited IL-10
activity in these samples, although we used a large excess of antibody.
Elevated serum and lymph node IL-10 levels have been described inamples following IFN-γ stimulation. CD4+ T cells from healthy controls, HIV-1 infected
for 1–3 h. Panel A shows expression of SOCS-1 mRNA by CD4+ T cells. Levels of SOCS-1
ere analyzed in triplicate and data normalized to the expression of 18S ribosomal RNA.
nd 1.4-fold increased] and NVS patents were [2.0 and 2.1-fold increased]; while, HIV-1
at induction of IRF-1 in HIV-1 patients CD4+ T cells with progressive disease was 3.1 and
l CD4+ Tcells of 5.0 and 4.0-fold. ⁎Indicates a signiﬁcant difference by KruskalWallis test
131A. Yadav et al. / Virology 385 (2009) 126–133HIV infected people, and would likely have a similar effect on SOCS-1
induction to that shown here.
HIV-1 progressor CD4+ T cells express elevated levels of SOCS-1 mRNA
and lower levels of IRF-1 after IFN-γ stimulation
Because IFN-γ induction of IRF-1 was abrogated in the HIV-1 Tg rat,
likelydue to elevatedexpressionof SOCS-1,weanalyzedSOCS-1 and IRF-
1 mRNA levels by RT-PCR following IFN-γ stimulation of human CD4+ T
cells with 10 ng/ml of IFN-γ for 0, 1 h and 3 h. Figs. 7A, B shows that 3 h
after IFN-γ stimulation, CD4+ T cells from individuals with progressive
HIV-1 infection (n=7) showed a signiﬁcantly higher SOCS-1mRNA level
and signiﬁcantly lower IRF-1mRNA relative to those from either healthy
controls or NVS patients (n=8) as judged by the Kruskal Wallis test and
Dunn's multiple comparisons test: Pb0.05. These data suggest that
higher SOCS-1 levels in CD4+ T cells from untreated persons with
progressive HIV-1 abrogate IFN-γ induction of IRF-1.
Discussion
These results demonstrate that IL-10 induces elevated levels of
expression of SOCS-1 in CD4+ T cells, which appears in turn to lead to
deﬁciencies in effector memory Th1 responses by HIV-1 Tg rats
through dysregulation of the IFN-γ/IRF-1/IL-12 signaling network. In
support of this idea, IL-12p40 production by BMDCs fromHIV-1 Tg rats
in response to IFN-γ/LPS stimulation was increased when SOCS-1
expression was inhibited. It is likely that chronic IL-10 induced over-
expression of SOCS-1 leads to decreased IL-12p40 expression by
BMDCs and subsequent activation-induced IFN-γ, IRF-1 and IL-12Rβ1
expression by CD4+ T cells. This would be expected to have a
cumulative negative effect on IL-12/IFN-γ signal transduction, IL-12
responsiveness, and the generation and/or survival of memory CD4+ T
cellswith Th1 effector function. These data suggest that the situation is
similar in infectedhumans, since SOCS-1mRNAwas elevated in CD4+ T
cells from HIV-1 infected progressor patients and was correlated with
defective induction of IRF-1 following IFN-γ stimulation, compared to
healthy controls and HIV-1 NVS patients (HIV-infected patients with
undetectable HIV-1 viral load in the absence of therapy).
These defects could have additional consequences. IL-23 is a
recently identiﬁed heterodimeric cytokine consisting of the IL12p40
subunit and a novel protein (p19), and its heterodimeric receptor (IL-
23R) requires expression of IL-12Rβ1 subunit for signaling. IL-17-
producing T helper (Th17) cells differentiate from naïve CD4+ T cells in
response to transforming growth factor-β and IL-6 but also require IL-
23 for maintenance or expansion (Veldhoen et al., 2006). IL-17
production is reduced in both HIV-1 and SIV infections (Ndhlovu et
al., 2008; Raffatellu et al., 2008). We have found that IL-17 production
by Tg rat CD4+ Tcells is more than three fold lower than that of control
CD4+ T cells (W.R.; data not shown). Interestingly, IL-17 regulates the
expression of β-defensin-2 (Liang et al., 2006), a peptide with
antimicrobial properties that is also an inhibitor HIV-1 infection. Sun
et al. have also reported that β-defensin-2 is dramatically diminished
in the oral cavity of HIV-1 infected patients, predisposing them to oral
opportunistic infections (Sun et al., 2005). It is tempting to speculate
that overexpresssion of SOCS-1 negatively regulates the development/
maintenance of both Th1 and Th17 responses during HIV-1 disease.
A 50% knockdown of SOCS-1 mRNA expression was achieved in Tg
BMDCs after 48 h of stimulation with LPS and IFN-γ. IL-12p40
expression was increased about two-fold from both Tg and control
cells (Figs. 3A, B), proportional to the 50% knockdown of SOCS1, and
IL-10 levels in the same supernatants were reduced (data not shown).
These data raise the possibility that inhibiting SOCS-1 expression
would improve IL-12 responsiveness and the generation and/or
survival of Th1 effector/memory T cells by increasing IFN-γ signal
transduction efﬁciency, IRF-1 induction and IL-12Rβ1 expression. We
are currently investigating this possibility.HIV-1 infected progressor patients demonstrated elevated levels of
SOCS-1 mRNA and reduced IRF-1 mRNA in response to IFN-γ
signaling, suggesting that elevated SOCS-1 also inhibits IFN-γ induced
responses in this group of patients relative to uninfected controls or
NVS patients. We are currently investigating IL-12 responsiveness and
the role of SOCS-1 in modifying these responses in humans.
Collectively, these data suggest that IL-10 induction of SOCS-1
contributes to HIV pathogenesis by affecting both innate and adaptive
Th1 immune responses. Interleukin-10 is a key regulatory cytokine
that suppresses immune responses and blocks IFN-γ synthesis by DC-
stimulated Th1 cells, IL-5 and IL-2 production by T cells, and IL-1α, IL-
1β, IL-6 IL-8, IL-12 and TNF-α production bymonocytes. IL-10 induces
expression of both SOCS-1 and -3mRNA and inhibits STAT-1 activation
by IFN-γ. Activated macrophages from Tg rats produce high levels of
IL-10 (Chang et al., 2007) and we show here that LPS-stimulated Tg
BMDC also secrete increased IL-10, as well as decreased IL-12p40
(Fig. 1). We show here that rIL-10 scientiﬁcally induces SOCS-1mRNA
(Fig. 6A). Although supernatants from control BMDC induce SOCS-1
expression by control CD4+ T cells, induction is not as great as with
supernatants from Tg BMDC, and induction with Tg BMDC super-
natants (but not that of control BMDC) cannot be completely inhibited
with anti-IL-10, suggesting that other soluble factors from Tg BMDC
may also contribute to SOCS-1 mRNA induction (Fig. 6B). It appears
that IL-10 released in vivo from both dendritic and non-dendritic
sources may serve to increase constitutive levels of SOCS-1 mRNA in
CD4+ Tcells, similar towhat is shown in Fig. 6. Themechanism leading
to increased Il-10 expression is obviously a key question. Although we
do not yet have direct evidence for involvement of speciﬁc HIV-1
proteins, it has been shown that HIV-1 Nef may be secreted, induces
SOCS-1 protein and IL-10 in human cells (Qiao et al., 2006; Brigino
et al., 1997; Haraguchi et al., 1998).
In summary, defects in IL-12p40 production by HIV-1 Tg rats are
likely mediated by elevated IL-10 production by BMDC, leading to
induction of SOCS-1mRNA in BMDCs and CD4+ T cells. Increased basal
expression of SOCS-1 in CD4+ T cells from Tg rats is correlated with
decreased IFN-γ induction of IRF-1 mRNA and IL-12Rβ1 and a
decrease in IL-12-induced IFN-γ production from Th1 polarized
cells. Interestingly, increased expression of SOCS-1 in HIV-1 infected
progressor patients is also correlated with a decrease in IFN-γ
mediated induction of IRF-1 mRNA. We also demonstrated that IL-
12p40 production following IFN-γ and LPS stimulation of BMDCs from
HIV-1 Tg rats is increased after inhibition of SOCS-1 expression by RNA
interference. The outlined immune abnormalities suggest a causative
link between IL-10 induction of SOCS-1 and defects in IL-12p40
production by BMDCs and IRF-1 and IL-12Rβ1 by CD4+ T cells
following LPS and or IFN-γ signaling. This likely adversely affects IL-12
responsiveness and the development/maintenance of Th1 effector/
memory responses in the Tg rats. The decrease in IFN-γ and IL-12
responsiveness, IL-12 production and dysregulation in Th1 effector/
memory responses that characterize the Tg rats recapitulate several
aspects of the immune pathology associated with HIV-1 and AIDS in
humans. The results suggest a previously undescribed link between
high levels of SOCS-1, defects in the innate immune response as
determined by LPS induction of IL-12p40 in BMDCs, and dysregulation
in adaptive Th1 immune responses that could help explain the loss of
Th1 immune competence in AIDS patients. Obviously, a detailed
analysis using infected human cells will be important to establish the
relevance of our current ﬁndings to natural infection.
Materials and methods
HIV-1 Tg and non-Tg animals
The construction of the HIV transgene and production of the Tg rats
have been described (Reid et al., 2001). Mature (12–15 month old)
speciﬁc pathogen free (SPF) Tg rats and age-matched Fisher 344/NHsd
132 A. Yadav et al. / Virology 385 (2009) 126–133non-Tg rats were used in our analyses and were housed under
pathogen free conditions in microisolator cages on HEPA ﬁltered
ventilated racks. The University of Maryland School of Medicine
Animal Care and Use Committee approved the experimental protocol.
Human subjects
Subjects were recruited from the Institute of Human Virology
Clinical Research Unit. Written informed consent was obtained and
procedures on patient material were collected under a protocol
approved by the University of Maryland Committee on Human
Research. All patients included in the study were adult (29–
60 years). Thirty milliliters of blood were collected for analysis.
Inclusion criteria for viremic HIV+ progressors were as follows: (i) lack
of prior antiretroviral therapy or lack of antiretroviral therapy formore
than 60 days prior to study entry and (ii) viremia of N900 copies/ml, as
well as (iii) CD4+ count of N200 cells/μl (in order to ensure that enough
CD4+ T cells could be isolated for experiments). HIV-1 NVS, as
described previously, 30 were included if they had both: (i)
undetectable viral loads (b75 copies/ml) for at least 2 years without
antiretroviral drugs) (ii) CD4+ count of N600.
Sorting CD4+ T cells
CD4+ T cells were prepared from spleens of mature (9–12 month)
HIV-1 Tg rats and isogenic controls as described elsewhere (Coligan et
al., 1994; Reid et al., 2004). Brieﬂy, CD4+ T cells were isolated using
negative selection StemSep™ rat cell separation kits following the
manufacturer's instructions (16052A, StemCell Technologies, Vancou-
ver, BC). Naïve CD4+ T cells were deﬁned by a CD45RC+/CD62L+ cell
surface phenotype (Hylkema et al., 2000; Ramirez and Mason, 2000).
NaïveCD4+Tcellswereﬁrst stainedwith PE conjugatedmouse anti-rat
CD45RC (554888, BD PharMingen), followed by anti-PE microbeads
(Miltenyi Biotec, Auburn, CA) as described (Reid et al., 2004) and
positively selected by AutoMacs under conditions speciﬁed by the
manufacturer. The positive population was stained with FITC con-
jugated mouse anti-rat CD62L (PharMingen) and CD45RC+/CD62L+
purity determined by ﬂow cytometry as described previously (Reid et
al., 2004) and analyzed by FlowJo software. The sorted naïve T cell
population purity was ≥85%. For adult human patient samples CD4+ T
cells were separated from 40 ml of blood using the negative selection
RosetteSep® (15062, StemCell Technologies, Vancouver, BC) following
the manufacturer's protocol. The purity of CD4+ T cell population was
90–95% as determined by ﬂow cytometry.
BMDC culture
Bonemarrowwas prepared from the femur ofmature HIV-1 Tg and
age-matched Fisher 344 controls as described elsewhere (Grauer et al.,
2002). Brieﬂy, bone marrow cells were cultured in RPMI with 10% FBS
and/or StemSpan (09650, Cell Signaling Technology, Boston, MA) in
5 ng/ml rGM-CSF and rIL-4 (555111 and 555107, BD Biosciences)
for 6–7 days followed by 2.5 ng/ml rGM-CSF until day 8. Any
contaminating B cells or macrophages were separated by positive
section using AutoMacs (Miltenyi Biotec, Auburn, CA) under condi-
tions described by the manufacturer. Generally, B cells were removed
after staining with anti rat-CD45RA microbeads (Miltenyi Biotec,
Auburn, CA); while contaminating macrophages were separated by
staining with FITC conjugated mouse anti-rat CD68 followed by
binding to anti FITC microbeads.
Cytokine analysis by ELISA
Puriﬁed BMDCs (1.0×106) from Tg and control Fisher rats were
stimulated with 1 μg/ml LPS (List Biological, Campbell, CA) and their
supernatants collected. IL-12p40 and IL-10 levels were measuredusing ELISA cytokine detection kits (BioSource International, Camar-
illo, CA and R and D Systems, Minneapolis, MN, respectively) following
the instructions given by the suppliers. The production of IFN-γ was
measured with the Quantikine® Rat IFN-γ ELISA (R and D Systems).
The detection limits of these ELISAs are 3,10 and 10 pg/ml for IL-12, IL-
10 and IFN-γ respectively. For relevant statistical processing of the
data, all values below the detection limits were assigned a value
extrapolated the standard curve.
Real-time PCR for IL-12Rβ1, SOCS-1, and IRF-1
Relative levels of speciﬁc mRNAs were quantiﬁed by real-time RT-
PCR analyses using the IQ5 Multicolor Realtime PCR Detection System
(Bio-Rad Laboratory, Hercules, CA). For IL12Rβ1 mRNA determina-
tions, naïve CD4+ T cells were stimulated under Th1 conditions as
described (Kano et al., 2008). Alternatively, puriﬁed BMDCs or CD4+ T
cells were isolated from control and Tg rats and stimulated at 1.0×106
cell/ml for 24–48 h with LPS at 1 μg/ml or 1–3 h with IFN-γ or rIL-10
(BD Pharmingen, San Diego, CA) at 10 ng/ml or cultured 18 h in LPS
stimulated BMDC culture supernatants with or without anti IL-10
antibody (BD Pharmingen, San Diego, CA) at 50 ng/ml. Total cellular
RNA was prepared using an RNeasy mini kit (Qiagen, Valencia, CA).
Quantitative real-time RT-PCRwas carried out using a SYBRGreen PCR
kit (Biorad). The rat IL-12Rβ1 mRNA was ampliﬁed with: forward 5′-
tcg cat aca ttg gct taa aca g-3′ and reverse 5′-gaa gtc ctc agg gtt gcg-3′;
SOCS-1 mRNAwas ampliﬁed with: forward 5′-agc cat cct cgt cct cgt c-
3′ and reverse 5′-gcg gaa ggt gcg gaa gtg-3′; rat IRF-1 mRNA was
ampliﬁed with: forward 5′-agc cac caa tgc cta tca ctc-3′ and reverse 5′-
tgt tcc tgc tct ggt cct tc-3′. Human SOCS-1 mRNA was ampliﬁed with
the following primers: forward 5′-ttc tgt agg atg gta ggac-3′ and re-
verse 5′-gag gag gag gaa gag gag-3′; human IRF-1mRNAwas ampliﬁed
with: forward 5′-gac cag agc agg aac aag-3′ and reverse 5′-cca tca gag
aag gta tca gg-3′. Samples were run in triplicate and the yield of IL-
12Rβ1, SOCS-1 and IRF-1 PCR product was normalized to 18S RNA
using an rRNA primer set. To control for DNA contamination, equal
amounts of RNA were used without reverse transcriptase.
Cell culture
Naïve CD4+ T lymphocytes were cultured in RPMI 1640 as
previously described (Fujimoto et al., 2002) and stimulated with
plate-bound anti-CD3 plus anti-CD28 (10 μg/ml and 5 μg/ml
respectively, BD Pharmingen, San Diego, CA) under Th1 conditions,
for which anti-IL-4 antibody (10 μg/ml, BD Pharmingen) and rIL-12
(1 ng/ml, BD Pharmingen) were added to the culture media. For IL-
2Rβ1 mRNA expression, day 3–5 Th1 polarized CD4+ T cells were
harvested for RT-PCR as described above. For IL-12 induced IFN-γ, day
3–5 Th1 cells were washed, rested for 24 h and stimulated for an
additional 24 h with rIL-12 (1 ng/ml, BD Pharmingen) and super-
natants collected for IFN-γ ELISA as described above. For IL-10 induced
SOCS-1 mRNA analysis, non-Tg control CD4 T cells were stimulated
with rIL-10 (10 ng/ml BD Pharmingen) for 1 h; additionally, CD4+ T
cells from non-Tg controls were cultured for 18 h in supernatants from
LPS stimulated Tg and non-Tg control BMDC samples with/without
added anti-IL-10 (50 ng/ml, BD Pharmingen) antibody. Cells were
harvested and analyzed by RT-PCR as described above.
Nucleofection of siRNA
BMDCs from Fisher 344/NHsd controls and aged matched HIV-1 Tg
rats were cultured as described above for 8 days. For nucleofection of
immature BMDCs, 2.0×106 cells were re-suspended in Nucleofector
solution (100 μl), (Human Dendritic Cell Nucleofection kit VPA-1004,
Amaxa Biosystems) with 2.6 μg of SOCS-1 ON-TARGET plus SMART
siRNA pool (Dharmacon Inc.) and nucleofected using an Amaxa
Nucleofector and program X002. As a positive and negative control
133A. Yadav et al. / Virology 385 (2009) 126–133cells were nucleofected with ON-TARGET plus Cyclophillin B pool
(cat# D-001820-30-20) or Non-Targeting siRNA (cat# D-001810-01-
20), respectively (Dharmacon Inc.) Immediately after nucleofection,
cells were transferred into 500 μl of pre-warmed media conditioned
with 100 ng/ml IL-4 and 100 ng/ml GM-CSF for cells to recover for
18 h. BMDCs were stained with 7-AAD and examined for viability by
ﬂow cytometry. BMDCs were suspended in RPMI-1640 at 1.0×106/ml
and stimulated with 1 μg/ml LPS and 10 ng/ml rIFN-γ for indicated
times. Cells were pelleted and supernatants collected and analyzed for
IL-12p40 by ELISA. RNA was extracted from the collected cells and
analyzed by RT-PCR. Nucleofection efﬁciency was determined by the
percent Cyclophillin B mRNA inhibition. SOCS-1 mRNA inhibition was
determined by comparisons of SOCS-1 expression between SOCS-1
siRNA treated groups versus non-targeting group as recommended by
themanufacturer (Dharmacon Inc.). Expression of SOCS-1mRNA by Tg
and control DC was knocked down to 50% and 70%, respectively.
Statistics
Means were compared within and between two groups by the
Mann–Whitney test for samples exhibiting non-normal distribution.
For three groups, the Kruskal–Wallis test for groups exhibiting non-
normal distribution was used and followed by the Dunn's Multiple
Comparisons post hoc test. P values were considered signiﬁcant at
Pb0.05. Means were compared between identical groups by a paired
T-test. Generally, analysis between RT-PCR reference and treatment
group were considered signiﬁcantly different if the lower 95%
conﬁdence limit of the treatment group was N1.
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